947-60-4Relevant academic research and scientific papers
ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 1/2 COMPLEX
-
Page/Page column 18; 19; 20, (2014/02/16)
Provided are compounds, compositions and methods for treating Toll-like receptor 1/2 complex (TLRI/2) related inflammatory disorders. Small molecules, based on the benzotropolone scaffold, capable of influencing downstream signaling are dislcosed as well as methods of making and modifying these molecules. Also provided are methods for treating a subject for a clinical condition associated with Toll? like receptor complex 1/2 activation, comprising administering to the subject an effective amount of a benzotropolone compound.
